This course explores one of the most urgent frontiers in modern biomedical science: how the immune system responds to cancer and infection, and how genomic technologies and AI are reshaping what we can detect, predict, and treat. You study the biological dialogue between pathogens and hosts, tumours and immune cells, microbes and ecosystems, and you learn how these interactions can be modelled, measured, and, increasingly, redesigned.
Rather than treating infectious disease and cancer as separate domains, the course brings them into a single intellectual frame. You explore shared mechanisms such as immune evasion, inflammation, genomic instability, evolutionary pressure, and microbial adaptation, and you examine how these processes influence outcomes, from vaccine response and outbreak prediction to antimicrobial resistance and precision immunotherapy.
Designed for researchers, clinicians, bioengineers, and innovators, this course supports you to connect core scientific principles with pressing global health questions. Throughout, you are encouraged to think like a translational scientist: to look at evidence carefully, to hold uncertainty responsibly, and to ask what it would take for discovery to become safe and equitable practice.
This interdisciplinary course provides a structured, research-informed understanding of how genomics, immune biology, and AI are reshaping both infectious disease science and onco-immunology. You explore how pathogens evolve under immune and therapeutic pressure, how immune cells respond across time and tissue, and how microbial ecosystems influence cancer risk, treatment response, and systemic health.
Key themes include:
Throughout the course, learners are guided to engage with real scientific reasoning rather than surface-level summaries. You develop a disciplined ability to interpret claims, evaluate methods, and ask whether evidence is strong enough for clinical or public health translation.
By the end of the course, learners will be able to:
At Afer*Nova, each programme is shaped by evidence-informed educational design, combining academic depth with real-world relevance. The structure is deliberately cross-disciplinary, supporting learners across health sciences, data science, engineering, public health, and innovation.
Learners begin with flexible learning modules that build a strong knowledge base through:
This phase supports independent learning while building confidence in core concepts.
Learners take part in mentor-guided workshops focused on applied learning, featuring:
These sessions support critical thinking, collaboration, and scientific communication.
Programmes are refreshed periodically to reflect developments in genomics, immunotherapy, infectious disease dynamics, public health governance, and AI-enabled healthcare. This helps ensure learning remains current and aligned with evolving scientific and societal needs.
At Afer*Nova, teaching is designed to help you think like someone who carries responsibility. You learn to interpret evidence carefully, communicate uncertainty honestly, and make decisions that balance innovation with ethics and equity.
Teaching is delivered through case-based masterclasses, interactive labs, ethical simulations, and problem-solving workshops that mirror real-world research and public health complexity. Assessment supports development rather than performance alone. Learners may be assessed through:
Final submissions often take the form of a portfolio that demonstrates scientific understanding, translational reasoning, and ethical judgement.
Mentoring format and level of individual feedback may vary depending on cohort size, availability, and programme design. Any dissemination opportunities, including internal showcases or curated collections, are discretionary outcomes and are not guaranteed.
This programme is distinctive because it treats immunology as a bridge rather than a boundary. You learn how infection, inflammation, immune editing, and microbial ecosystems can shape tumour biology, and how cancer and treatment pressure can reshape immune landscapes and pathogen vulnerability. The aim is not only to teach concepts, but to cultivate systems-level insight into how biological and clinical realities interact.
You are encouraged to think beyond what is possible and toward what is responsible. This includes careful exploration of governance questions such as genomic privacy, consent, global data equity, interpretability of AI in high-stakes contexts, and the ethical risks of surveillance models that disproportionately affect vulnerable communities. You learn how to weigh public health urgency against long-term trust and protection.
Where appropriate and subject to programme design, learners may explore curated bioinformatics platforms and public datasets used in genomic surveillance and microbiome analysis. You are guided to use tools with an interpretive mindset: not just running pipelines, but asking what the outputs mean, what they miss, and how uncertainty should be communicated.
Important note: Specific tools and datasets may vary depending on cohort design and access conditions.
Learners may produce a structured written output, such as a research-style review, case analysis, or policy brief. Subject to quality review and programme design, selected work may be considered for inclusion in curated student collections or internal showcases.
Any opportunities for dissemination, publication guidance, or reference letters are discretionary and are not guaranteed.
Students may:
If you wish to enroll in the course, please click the ‘Register Now’ button. Our team will reach out to you after reviewing your academic qualifications.